Please login to the form below

Not currently logged in
Email:
Password:

National Dementia Declaration launched

The UK's National Institute for Health and Clinical Excellence has joined forces with 44 other organisations to form Dementia Action Alliance

A total of 45 organisations, including the UK's National Institute for Health and Clinical Excellence (NICE), have united to form the Dementia Action Alliance, which aims to bring about radical changes in the way society responds to dementia.

As a first step towards achieving this change, the Alliance has launched the National Dementia Declaration; a charter that spells out exactly what each Alliance member plans to do to improve the quality of life for people with dementia in England. 

Created in partnership with people with dementia and their carers, the declaration explains the challenges dementia presents to society and some of the outcomes being sought for people with dementia and their carers. 

Outcomes range from ensuring people with dementia have choice and control over decisions about their lives, to feeling a valued part of family, community and civic life.

Signatories to the declaration have published their own action plans setting out what they will do to secure these outcomes and improve the quality of life of people with dementia by 2014.

Commitments include promoting information on dementia to councils and delivery of a national project on the care of people with dementia in hospitals, adapting practice to better reflect the needs of people with dementia, increasing dementia-specific training and campaigning for a more prominent place for dementia on the policy and research agendas.

NICE's contribution to the declaration is the development of a quality standard on dementia care.

NICE's dementia quality standard sets out a vision of what high-quality care should look like for dementia patients on the NHS. It is underpinned by the joint NICE/Social Care Institute for Excellence (SCIE) clinical guideline on dementia care and appraisals on medicines relevant to the condition such as donepezil (Aricept), galantamine (Reminyl), rivastigmine (Exelon) and memantine (Ebixa).

UK care services minister, Paul Burstow, commented: "This Dementia Declaration shows tremendous commitment from across health and care services and the voluntary sector, to transform services and tackle stigma to make a difference for people with dementia and their families. Willingness to join forces to act should spur more organisations to join this movement for change."

27th October 2010

From: Healthcare

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

APAC map
Pharmaceutical innovation in the APAC region
A first-of-its-kind study paints a vivid picture of the APAC region’s future...
Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...
Precision medicine at Blue Latitude Health
At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and...

Infographics